Anaptysbio (ANAB) Return on Invested Capital (2019 - 2024)
Historic Return on Invested Capital for Anaptysbio (ANAB) over the last 6 years, with Q3 2025 value amounting to 0.77%.
- Anaptysbio's Return on Invested Capital rose 39000.0% to 0.77% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77%, marking a year-over-year increase of 39000.0%. This contributed to the annual value of 1.45% for FY2024, which is 5100.0% down from last year.
- Anaptysbio's Return on Invested Capital amounted to 0.77% in Q3 2025, which was up 39000.0% from 16.09% recorded in Q2 2025.
- In the past 5 years, Anaptysbio's Return on Invested Capital ranged from a high of 16.09% in Q2 2025 and a low of 5.63% during Q2 2024
- For the 3-year period, Anaptysbio's Return on Invested Capital averaged around 0.09%, with its median value being 1.75% (2023).
- Per our database at Business Quant, Anaptysbio's Return on Invested Capital skyrocketed by 1000bps in 2024 and then skyrocketed by 217200bps in 2025.
- Quarter analysis of 3 years shows Anaptysbio's Return on Invested Capital stood at 1.58% in 2023, then increased by 6bps to 1.48% in 2024, then skyrocketed by 152bps to 0.77% in 2025.
- Its Return on Invested Capital stands at 0.77% for Q3 2025, versus 16.09% for Q2 2025 and 1.91% for Q1 2025.